Bazemore Robert B bought AKTX
October 14, 2026 · Form 4 insider transaction
Bazemore Robert B bought 773 shares of Akari Therapeutics, Plc at $0.00 per share, a transaction worth $0.31. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
773
Price
$0.00
Total value
$0.31
InsiderBazemore Robert B
Role—
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeM: Option exercise
Transaction dateOctober 14, 2026
Filing dateOctober 16, 2026
Shares owned after19,666
OwnershipDirect
10b5-1 planNo
AmendedNo